ID   CBC3T-6
AC   CVCL_E5HL
RX   PubMed=39613883;
CC   Population: Chinese.
CC   Characteristics: Highly tumorigenic (PubMed=39613883).
CC   Doubling time: ~50 hours (PubMed=39613883).
CC   Karyotypic information: Nearly triploid (PubMed=39613883).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=39613883).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Unspecified (PubMed=39613883).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=39613883
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 20,22
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13.3,14.3
ST   D19S433: 14,14.2
ST   D21S11: 30,31
ST   D2S1338: 22,23
ST   D2S441: 11,15
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D6S1043: 19
ST   D7S820: 11,13
ST   D8S1179: 12
ST   FGA: 21,25
ST   Penta D: 11,15
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C7976; Distal cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=39613883; DOI=10.1038/s41598-024-81392-0; PMCID=PMC11607416;
RA   Bai M.-Z., Wang R.-S., Huang C.-F., Zhong R.-Y., Jiang N.-Z., Fu W.-K.,
RA   Mi N.-N., Gao L., Jin Y.-Y., Ma H.-D., Cao J., Yu H.-Y., Jing Q.,
RA   Zhang C., Yue P., Zhang Y., Lin Y.-Y., Zhang H.-W., Meng W.-B.;
RT   "Biological and genetic characterization of a newly established human
RT   primary multidrug-resistant distal cholangiocarcinoma cell line,
RT   CBC3T-6.";
RL   Sci. Rep. 14:29661.1-29661.12(2024).
//